Evidence map›Paper›PMID 29064456›Full record

ReviewInternational journal of molecular sciences2017

Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.

W Ted Allison, Michèle G DuVal, Kim Nguyen-Phuoc, Patricia L A Leighton

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Interstitial 20p13 microdeletion includingClinical case reports · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

W Ted AllisonCentre for Prions & Protein Folding Disease, University of Alberta, Edmonton, AB T6G 2M8, Canada. ted.allison@ualberta.ca.ORCID 0000-0002-8461-4864
Michèle G DuValDepartment of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada. mgduval@ualberta.ca.ORCID 0000-0001-6975-8117
Kim Nguyen-PhuocCentre for Prions & Protein Folding Disease, University of Alberta, Edmonton, AB T6G 2M8, Canada. thienkim@ualberta.ca.
Patricia L A LeightonCentre for Prions & Protein Folding Disease, University of Alberta, Edmonton, AB T6G 2M8, Canada. pleighto@ualberta.ca.
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prions have served as pathfinders that reveal many aspects of proteostasis in neurons. The recent realization that several prominent neurodegenerative diseases spread via a prion-like mechanism illuminates new possibilities for diagnostics and therapeutics. Thus, key proteins in Alzheimer Disease and Amyotrophic lateral sclerosis (ALS), including amyloid-β precursor protein, Tau and superoxide dismutase 1 (SOD1), spread to adjacent cells in their misfolded aggregated forms and exhibit template-directed misfolding to induce further misfolding, disruptions to proteostasis and toxicity. Here we invert this comparison to ask what these prion-like diseases can teach us about the broad prion disease class, especially regarding the loss of these key proteins' function(s) as they misfold and aggregate. We also consider whether functional amyloids might reveal a role for subverted protein function in neurodegenerative disease. Our synthesis identifies SOD1 as an exemplar of protein functions being lost during prion-like protein misfolding, because SOD1 is inherently unstable and loses function in its misfolded disease-associated form. This has under-appreciated parallels amongst the canonical prion diseases, wherein the normally folded prion protein, PrP

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAmyotrophic Lateral SclerosisAnimalsHumansPrion DiseasesPrion ProteinsProtein FoldingSuperoxide Dismutase-1tau ProteinsAmyloid beta-PeptidesPrion ProteinsSuperoxide Dismutase-1tau Proteinsamyotrophic lateral sclerosisfunctional amyloidpremelanosome protein (PMEL17)prion-like diseaseprotein homeostasisscrapieSOD1strains

Identifiers

PMID29064456
PMCPMC5666902
OpenAlexW2767062265

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.